Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype

Abstract

Cervical cancer is associated with human papilloma virus infection. However, this infection is insufficient to induce transformation and progression. Loss of heterozygosity analyses suggest the presence of a tumor suppressor gene (TSG) on chromosome 6p21.3–p25. Here we report the cloning NOL7, its mapping to chromosome band 6p23, and localization of the protein to the nucleolus. Fluorescence in situ hybridization analysis demonstrated an allelic loss of an NOL7 in cultured tumor cells and human tumor samples. Transfection of NOL7 into cervical carcinoma cells inhibited their growth in mouse xenografts, confirming its in vivo tumor suppressor activity. The induction of tumor dormancy correlated with an angiogenic switch caused by a decreased production of vascular endothelial growth factor and an increase in the production of the angiogenesis inhibitor thrombospondin-1. These data suggest that NOL7 may function as a TSG in part by modulating the expression of the angiogenic phenotype.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  • Bouck N, Stellmach V, Hsu H . (1995). Adv Cancer Res 69: 135–174.

  • Cannistra SA, Niloff JM . (1996). N Engl J Med 334: 1030–1038.

  • Chen T, Pecoraro G, Defendi V . (1993). Cancer Res 53: 1167–1171.

  • Chen Z, Issa B, Brothman LJ, Hendricksen M, Button D, Brothman AR . (2000). Cancer Genet Cytogenet 121: 22–25.

  • Claudio PP, Stiegler P, Howard CM, Bellan C, Minimo C, Tosi GM et al. (2001). Cancer Res 61: 462–468.

  • Coignet LJ, Lima CS, Min T, Streubel B, Swansbury J, Telford N et al. (1999). Genes Chrom Cancer 25: 222–229.

  • Dameron KM, Volpert OV, Tainsky MA, Bouck N . (1994). Science 2651: 582–584.

  • Dejong V, Degeorges A, Filleur S, Ait-Si-Ali S, Mettouchi A, Bornstein P et al. (1999). Oncogene 18: 3143–3151.

  • Gnarra JR, Zhou S, Merrill MJ, Wagner JR, Krumm A, Papavassiliou E et al. (1996). Proc Natl Acad Sci USA 93: 10589–10594.

  • Hanahan D, Folkman J . (1996). Cell 86: 353–364.

  • Huettner PC, Gerhard DS, Li L, Gersell DJ, Dunnigan K, Kamarasova T et al. (1998). Hum Pathol 29: 364–370.

  • Jinawath N, Furukawa Y, Nakamura Y . (2004). Cancer Sci 95: 430–435.

  • Kersemaekers AM, Kenter GG, Hermans J, Fleuren GJ, van de Vijver MJ . (1998). Int J Cancer 79: 411–417.

  • Kraemer M, Tournaire R, Dejong V, Montreau N, Briane D, Derbin C et al. (1999). Cell Growth Differ 10: 193–200.

  • Lazo PA . (1999). Br J Cancer 80: 2008–2018.

  • Lingen MW . (2002). Wound Healing: Methods and Protocols. Totowa, NJ: Humana Press, Inc, pp. 337–347.

    Google Scholar 

  • Lingen MW, DiPietro LA, Solt DB, Bouck NP, Polverini PJ . (1997). Carcinogenesis 18: 329–338.

  • Lingen MW, Polverini PJ, Bouck NP . (1998). Cancer Res 58: 5551–5558.

  • Marconcini L, Marchio S, Morbidelli L, Cartocci E, Albini A, Ziche M et al. (1999). Proc Natl Acad Sci USA 96: 9671–9676.

  • Mitra AB, Murty VV, Li RG, Pratap M, Luthra UK, Chaganti RS . (1994). Cancer Res 54: 4481–4487.

  • Montgomery K, Tedford KL, McDougall JK . (1995). Genes Chromosomes Cancer 14: 97–105.

  • Mukhopadhyay D, Tsiokas L, Sukhatme VP . (1995). Cancer Res 55: 6161–6165.

  • Mullokandov MR, Kholodilov NG, Atkin NB, Burk RD, Johnson AB, Klinger HP . (1996). Cancer Res 56: 197–205.

  • Nagai H, Kinoshita T, Suzuki H, Hatano S, Murate T, Saito H . (1999). Genes Chromosomes Cancer 25: 277–283.

  • Nakase K, Wakita Y, Minamikawa K, Yamaguchi T, Shiku H . (2000). Leuk Res 24: 79–81.

  • Olson MO, Dundr M, Szebeni A . (2000). Trends Cell Biol 10: 189–196.

  • Rader JS, Li Y, Huettner PC, Xu Z, Gerhard DS . (2000). Genes Chromosomes Cancer 27: 373–379.

  • Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T et al. (1995). Cancer Res 55: 4575–4580.

  • Sheibani N, Frazier WA . (1996). Cancer Lett 107: 45–52.

  • Slack JL, Bornstein P . (1994). Cell Growth Differ 5: 1373–1380.

  • Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF et al. (1992). Carcinogenesis 13: 1273–1275.

  • Sugimoto M, Kuo M-L, Roussel MF, Sherr CJ . (2003). Mol Cell 11: 415–424.

  • Takeshita A, Naito K, Shinjo K, Sahara N, Matsui H, Ohnishi K et al. (2004). Cancer Genet Cytogenet 152: 56–60.

  • Tikhonenko AT, Black DJ, Linial ML . (1996). J Biol Chem 271: 30741–30747.

  • Uejima H, Mitsuya K, Kugoh H, Horikawa I, Oshimura M . (1995). Genes Chromosomes Cancer 14: 120–127.

  • Visintin R, Amon A . (2000). Curr Opin Cell Biol 12: 372–377.

  • Volpert OV, Dameron KM, Bouck N . (1997). Oncogene 14: 1495–1502.

  • Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV et al. (1999). J Pathol 189: 12.

  • Watnick RS, Cheng YN, Rangarajan A, Ince TA, Weinberg RA . (2003). Cancer Cell 3: 219–231.

  • Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D . (1999). Nat Cell Biol 1: 20–29.

  • Wen S, Stolarov J, Myers MP, Su JD, Wigler MH, Tonks NK et al. (2001). Proc Natl Acad Sci USA 98: 4622–4627.

  • Wolf JK, Ramirez PT . (2001). Cancer Invest 19: 621–629.

  • Yaginuma Y, Westphal H . (1991). Cancer Res 51: 6506–6509.

  • Zabrenetzky V, Harris CC, Steeg PS, Roberts DD . (1994). Int J Cancer 59: 191–195.

  • Zhang YW, Su Y, Volpert OV, Vande Woude GF . (2003). Proc Natl Acad Sci USA 100: 12718–12723.

Download references

Acknowledgements

This work was supported in part by the NIH grants: DE12322 and DE00470 (MWL).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M W Lingen.

Additional information

Supplementary Information accompanies the paper on Oncogene website (http://www.nature.com/onc)

Supplementary information

supplementary Table

26 Commonly Upregulated Genes in SiHa Clone 3 and Clone 4 When Compared to SiHa Parental (XLS 63 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hasina, R., Pontier, A., Fekete, M. et al. NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype. Oncogene 25, 588–598 (2006). https://doi.org/10.1038/sj.onc.1209070

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209070

Keywords

This article is cited by

Search

Quick links